Elyssa Rubin
Pediatric Hematology-Oncology · Orange, CANPI 1578738282
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,500 of the $3,582 with a category attached, or 69.8%. Foundation Medicine, Inc. accounts for 82.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $2,656 and has fallen 98.1% since, to $52 in 2025.
Across 27 payments — averaging $132.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Foundation Medicine, Inc.$3K
- Sobi, Inc$253
- Servier Pharmaceuticals LLC$163
- Jazz Pharmaceuticals Inc.$99
- Takeda Pharmaceuticals U.S.A., Inc.$58
- AstraZeneca$23
- plus $37 from 2 others
Across 59 payments — averaging $19,365 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$1M
- Pfizer$30K
- Incyte Corporation$29K
- E.r. Squibb & Sons, L.L.C.$21K
- Eisai Inc.$20K
- Genentech, Inc.$18K
- plus $2K from 1 others
What the payments were for
- Speaking & faculty fees$2,50070%
- Travel & lodging$38311%
- Food & beverage$57016%
- Education$1294%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Foundation Medicine, Inc. | 4 | $2,949 |
| Sobi, Inc | 6 | $253 |
| Servier Pharmaceuticals LLC | 8 | $163 |
| Jazz Pharmaceuticals Inc. | 4 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| AstraZeneca | 1 | $23 |
| Merck | 1 | $19 |
| Amgen | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FOUNDATIONFOCUS$2,883
- FOUNDATIONONE CDX$2,883
- FOUNDATIONONE HEME$2,883
- FOUNDATIONONE$2,883
- FOUNDATIONACT$2,383
- FOUNDATIONONE LIQUID$500
How this compares
$3,582 in reported general payments places this provider in the 65th percentile of 307 pediatric hematology-oncology providers in California.
See all pediatric hematology-oncology providers in California →
Other pediatric hematology-oncology in Orange
- Vanessa Salinas-LunaOrange$344K
- Arash MahajerinOrange$249K
- Amit SoniOrange$70K
- Esteban GomezOrange$56K
- Diane NugentOrange$55K
- van HuynhOrange$37K
- Mariko SatoOrange$21K
- Philip PizzoPalo Alto$2.6M
- Vinod BalasaMadera$508K
- Akshat JainRedlands$447K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.